Updates are available Correction dated 2022-09-26
Click to view Correction: https://doi.org/10.1186/s13054-022-04169-9
-
Authors
Merliot-Gailhoustet, Lili
Raimbert, Chloé
Garnier, Océane
Carr, Julie
De Jong, Audrey
Molinari, Nicolas
Jaber, Samir
Chanques, Gerald
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 21 August 2022
First Online: 3 September 2022
Change Date: 26 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13054-022-04169-9
Declarations
:
: The study was approved by an ethics committee [Comité de Protection des Personnes Sud-Méditerranée-1 (ID-RCB:2016-A00748-43)] according to French law and registered on Clinical Trials NCT04017299.
: Adult patients over 18-yo admitted to the ICU were eligible if they were alert and nondelirious, following the French validated versions of the Confusion Assessment Method for the ICU (CAM-ICU) [CitationRef removed, CitationRef removed] and the Richmond Agitation Sedation Scale (RASS) that had to be ≥ 0 [CitationRef removed]. Patients were screened daily for eligibility by investigators and included in the study after written consent.
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Samir Jaber reports consulting fees from Drager, Xenios, Medtronic and Fisher and Paykel. Other authors declare no conflicts of interest. The music therapy system was purchased by the hospital several years before the study. The two virtual reality systems were lent to the hospital by the manufacturers for a free test. Manufacturers gave their consent for the evaluation study but had strictly no implication on the study design, data analysis, and study reporting.
